PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
F Sellebjerg Selected Research
Methylprednisolone
02/2003
Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosis.
04/2002
Cerebrospinal fluid levels of nitric oxide metabolites predict response to methylprednisolone treatment in multiple sclerosis and optic neuritis.
08/2000
A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations.
05/2000
Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis.
Articles by Research Topic
Disease
17
Multiple Sclerosis
06/2008 - 01/2000
5
Optic Neuritis (Retrobulbar Neuritis)
03/2005 - 05/2000
2
Inflammation
11/2001 - 04/2000
1
Syndrome
10/2006
Drug/Important Bio-Agent (IBA)
4
Interferon-beta
IBA
06/2008 - 08/2006
4
Methylprednisolone
FDA Link
Generic
02/2003 - 05/2000
2
Interferons
IBA
06/2007 - 12/2005
2
CXCR3 Receptors
IBA
09/2004 - 04/2002
1
Messenger RNA (mRNA)
IBA
06/2008
1
Interleukin-23 (Interleukin 23)
IBA
06/2008
1
Interleukin-10 (Interleukin 10)
IBA
06/2008
1
CCR5 Receptors (CCR5 Receptor)
IBA
06/2007
1
tetranectin
IBA
01/2006
1
Immunoglobulins (Immunoglobulin)
IBA
03/2005
1
Ligands
IBA
09/2004
1
Chemokine CCL2 (Monocyte Chemoattractant Protein 1)
IBA
07/2004
1
CCR2 Receptors
IBA
07/2004
1
CCR Receptors
IBA
03/2003
1
Gadolinium
IBA
02/2003
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
04/2002
1
Chemokine Receptors
IBA
01/2002
1
Chemokines
IBA
11/2001
1
Immunoglobulin G (IgG)
IBA
08/2000
1
HLA-DRB1 antigen (HLA DRB1)
IBA
04/2000
1
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
01/2000